Dr. Diego Martin Rubinowicz , MD
Urology • Loxahatchee, FL
13005 Southern Blvd Ste 135
Loxahatchee, FL 334709231
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 10, 2006; this date does not establish years in practice.
-
Published CMS data list 2,929 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 660 service units.
- 81003 — Automated urinalysis test: 557 service units.
- 82570 — Creatinine level to test for kidney function or muscle injury: 556 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 17 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,278 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Alfuzosin Hcl Er (Alfuzosin Hcl) — 491 prescription fills, including refills.
- Finasteride — 312 prescription fills, including refills.
- Tamsulosin Hcl — 267 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: 1,437. Middle half: 569 to 4,607.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,733 in 2020 to 2,929 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
13005 Southern Blvd Ste 135
Loxahatchee, FL 334709231
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Medical College Of Wisconsin
1995
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
461 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $211,337 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $164,630 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
4,467 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$237,470 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $590.92 across 23 records.
By nature of payment
- Food and Beverage: $590.92 across 23 records.
Reporting-company totals (3 largest of 13)
- Procept Biorobotics Corporation: $176.00 across 2 records.
- Janssen Pharmaceuticals, Inc: $96.02 across 5 records.
- Astellas Pharma US Inc: $55.20 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
31 years (graduated 1995)
CMS Doctors and Clinicians data list 1995 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Rubinowicz has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Rubinowicz as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Loxahatchee and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: 1,437. Middle half: 569 to 4,607.
Too few clinicians listed under Urology in Loxahatchee have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 65% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: $126,394. Middle half: $52,949 to $270,891.
Too few clinicians listed under Urology in Loxahatchee have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: $92,960. Middle half: $39,365 to $204,092.
Too few clinicians listed under Urology in Loxahatchee have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Urology in Florida (2024, 725 clinicians with data). Median for this group: 1,339. Middle half: 366 to 2,301.
Too few clinicians listed under Urology in Loxahatchee have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Urology in Florida (2024, 725 clinicians with data). Median for this group: $137,247. Middle half: $24,439 to $468,865.
Too few clinicians listed under Urology in Loxahatchee have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Urology with a practice address in Loxahatchee, FL (1,021 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 69% from 1,733 in 2020 to 2,929 in 2024.
- 2020: 1,733
- 2021: 2,582
- 2022: 3,019
- 2023: 2,847
- 2024: 2,929
-
Medicare-allowed amount
Medicare-allowed amount increased 54% from $137,267 in 2020 to $211,337 in 2024.
- 2020: $137,267
- 2021: $215,905
- 2022: $232,030
- 2023: $213,236
- 2024: $211,337
-
Paid by Medicare
Paid by Medicare increased 65% from $99,898 in 2020 to $164,630 in 2024.
- 2020: $99,898
- 2021: $164,278
- 2022: $176,080
- 2023: $166,592
- 2024: $164,630
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 23% from 1,849 in 2020 to 2,278 in 2024.
- 2020: 1,849
- 2021: 1,962
- 2022: 2,035
- 2023: 2,212
- 2024: 2,278
-
30-day fills
30-day fills increased 27% from 3,529 in 2020 to 4,467 in 2024.
- 2020: 3,529
- 2021: 3,731
- 2022: 3,971
- 2023: 4,232
- 2024: 4,467
-
Part D drug cost
Part D drug cost increased 197% from $79,956 in 2020 to $237,470 in 2024.
- 2020: $79,956
- 2021: $105,523
- 2022: $139,156
- 2023: $232,448
- 2024: $237,470
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $649.84 in 2021 to $590.92 in 2025.
- 2021: $649.84
- 2022: $1,134.91
- 2023: $1,179.18
- 2024: $983.84
- 2025: $590.92
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $590.92.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $151.02 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $28.70 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $27.82 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $26.50 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $24.98 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $23.77 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $23.27 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $21.96 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $20.69 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $20.62 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $19.72 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $19.39 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $19.25 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $19.18 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $17.33 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $17.18 |
| Philips North America LLC |
Food and Beverage
Cash or cash equivalent
|
Oncology Solution | General | $16.84 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $15.70 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $15.64 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $15.56 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $15.51 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $15.16 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $15.13 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
660 | 361 | $221.00 | $128.88 |
|
81003
Automated urinalysis test
|
557 | 365 | $20.00 | $2.20 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
556 | 365 | $20.00 | $5.08 |
|
J3490
Unclassified drugs
|
396 | 21 | $329.55 | $112.84 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
215 | 145 | $150.00 | $91.64 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
143 | 107 | $42.00 | $11.33 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
131 | 131 | $344.00 | $169.78 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
50 | 48 | $443.00 | $239.63 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
37 | 17 | $91.00 | $56.98 |
|
11980
Placement of hormone pellet under skin
|
35 | 21 | $228.00 | $49.39 |
|
12001
Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less
|
34 | 21 | $203.00 | $96.57 |
|
76872
Ultrasound scan of pelvic region through rectum
|
34 | 34 | $294.00 | $136.38 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
21 | 20 | $427.00 | $37.06 |
|
51741
Electronic assessment of bladder emptying
|
19 | 18 | $54.00 | $7.39 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
16 | 15 | $666.00 | $360.30 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
14 | 12 | $287.00 | $107.17 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
11 | 11 | $261.00 | $186.86 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alfuzosin Hcl Er | Alfuzosin Hcl | 491 | 32,058 | $8,275.92 | 144 |
| Finasteride | Finasteride | 312 | 23,318 | $3,014.04 | 100 |
| Tamsulosin Hcl | Tamsulosin Hcl | 267 | 20,755 | $3,104.89 | 90 |
| Cephalexin | Cephalexin | 213 | 2,000 | $519.04 | 131 |
| Dutasteride | Dutasteride | 177 | 13,472 | $5,578.79 | 58 |
| Gemtesa | Vibegron | 85 | 4,217 | $65,452.44 | 25 |
| Methenamine Hippurate | Methenamine Hippurate | 82 | 4,716 | $4,479.95 | 21 |
| Myrbetriq | Mirabegron | 74 | 3,660 | $56,091.29 | 29 |
| Testosterone Cypionate | Testosterone Cypionate | 72 | 2,016 | $2,979.49 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 246 | $111.45 | 48 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 48 | 1,362 | $488.67 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 44 | 161 | $252.86 | 36 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 248 | $97.31 | 35 |
| Imipramine Hcl | Imipramine Hcl | 35 | 2,197 | $415.35 | — |
| Estradiol | Estradiol | 32 | 2,219 | $1,961.49 | 15 |
| Solifenacin Succinate | Solifenacin Succinate | 31 | 1,540 | $1,071.81 | 11 |
| Potassium Citrate Er | Potassium Citrate | 27 | 1,885 | $2,319.53 | — |
| Sildenafil Citrate | Sildenafil Citrate | 27 | 907 | $80.68 | 16 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | 1,050 | $830.23 | — |
| Xyosted | Testosterone Enanthate | 19 | 532 | $11,716.31 | — |
| Testosterone | Testosterone | 18 | 660 | $1,564.82 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | 165 | $168.19 | 14 |
| Trelstar | Triptorelin Pamoate | 17 | 2,430 | $66,556.87 | 12 |
| Fluconazole | Fluconazole | 15 | 15 | $38.58 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 15 | $68.44 | 15 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20040924000175
FL
0345218624
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 13005 SOUTHERN BLVD STE 135, LOXAHATCHEE, FL 334709231 (Tel: 5616151234)
Registered at 13005 SOUTHERN BLVD STE 135, LOXAHATCHEE, FL 334709231 (Tel: 5616151234)
NPI status registered as active in NPPES database
Registered at 12983 SOUTHERN BLVD, SUITE 206, LOXAHATCHEE, FL 334709207 (Tel: 5616151234)
Registered at 12983 SOUTHERN BLVD, SUITE 206, LOXAHATCHEE, FL 334709207 (Tel: 5616151234)
Recorded as DIEGO RUBINOWICZ, M.D.
Urology (license number reported to NPPES: FL ME81113)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
13005 Southern Blvd Ste 135
Loxahatchee, FL 334709231
Phone: 5616151234